Advertisement

U.S. markets closed

S&P Futures
4,217.75
+7.75(+0.18%)
Dow Futures
33,329.00
+69.00(+0.21%)
Nasdaq Futures
13,426.00
+34.00(+0.25%)
Russell 2000 Futures
1,972.90
+3.40(+0.17%)
Crude Oil
91.41
-0.52(-0.57%)
Gold
1,805.50
-8.20(-0.45%)

Advertisement

Agenus Inc. (AGEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

2.6700

+0.1100

(+4.30%)

At close: 04:00PM EDT

2.6100

-0.06

(-2.25%)

After hours:

07:59PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	2.5600
Open	2.6700
Bid	2.6100 x 21500
Ask	2.6600 x 21500
Day's Range	2.5000 - 2.6750
52 Week Range	1.2500 - 6.7900
Volume	4,762,928
Avg. Volume	5,164,445

Market Cap	755.234M
Beta (5Y Monthly)	1.20
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0770
Earnings Date	Nov 07, 2022 - Nov 11, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	9.67

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AGEN

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Agenus Inc.
Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
Rating
Fair Value
Economic Moat
4 months agoMorningstar